Abstract:Leecarlo Millano Lumban Gaol, 1– 3 Ambrosius Purba, 1 Rizki Diposarosa, 1, 2 Yuni Susanti Pratiwi 1 1 Faculty of Medicine Padjadjaran University, Bandung, Indonesia; 2 Dr. Hasan Sadikin General Hospital, Bandung, Indonesia; 3 Faculty of Medicine Krida Wacana Christian University, Jakarta, Indonesia Correspondence: Leecarlo Millano Lumban Gaol, Faculty of Medicine Padjadjaran University, Raya Bandung Sumedang Street No. 21, Hegarmanah, Jatinangor, Sumedang, Bandung, West Java, 45363, Indonesia, Email Background: Fecal incontinence (FI) is the inability to control bowel movements, resulting in fecal leakage. If left untreated, FI can seriously impact the long-term well-being of individuals affected. Recently, using secretome has become a promising new treatment method. The secretome combines growth factors released outside cells during stem cell development, such as mesenchymal stem cells. It consists of soluble proteins, nucleic acids, fats, and extracellular vesicles, which contribute to different cell processes. The primary aim is to assess the impact of hypoxic secretome administration on accelerating wound healing through the HIF-1α pathway in a post-sphincterotomy rat model. Methods: The study was conducted with two distinct groups of 10 rats each, the control and treatment groups, which were injected with hypoxic secretome at 0.3 mL. The inclusion criteria for the rats were as follows: male gender, belonging to the Sprague-Dawley strain, aged between 12 to 16 weeks, with an average body weight ranging from 240 to 250 grams. Results: There was an increase in HIF-1α gene expression in both groups. The treatment group 37 was significantly higher on day 42 (p = 0.001). VEGF increased significantly in the treatment 38 group on day 42 (p = 0.015). The neovascularization score increased significantly in the treatment 39 group during the first 24 hours (p = 0.004). The fibroblast score increased significantly in the 40 treatment group in the first 24 hours (p = 0.000) and 42 days (p = 0.035). After being given secretome, there was a higher increase in % collagen area and collagen area (μm 2 ) in the treatment group compared to the control group (27,77 vs 11.01) and (419.027,66 vs 186.694,16). Conclusion: The use of hypoxic secretome has a significant effect as a choice for the treatment of anal sphincter injury after sphincterotomy through the HIF-1α-VEGF-Fibroblast pathway. Keywords: fecal incontinence, fibroblast, HIF-1α, hypoxic secretome, neovascularization, VEGF Fecal incontinence (FI) is an involuntary passage of liquid and/or solid feces that negatively affects the quality of life, with prevalence ranging from 7% to 15% In the general population. 1 In patients with fecal incontinence, various physical and psychological disorders can occur, such as recurrent infections, ulcers and skin scars, social anxiety disorders, behavioral problems, self-deprecation or isolation, and other problems that give rise to feelings of guilt and shame. 2–4 FI can begin in childhood and persist into adulthood. Among children, the incidence rates of FI vary from 1.6% to 4.4%, and boys have more potential to suffer from fecal incontinence. 5 The leading cause is often associated with surgeries such as internal sphincterotomy and fistulotomy, which account for 35–45% of FI occurrences. 6–8 Various efforts have been made to prevent FI after surgical procedures, including conventional therapies like enema use, neurostimulation/biofeedback, and reoperation. However, the outcomes of these methods have often been unsatisfactory, leading to persistent FI, surgical wound infections, rectal prolapse, and other complications. 9 Anoplasty alone is not compelling enough to achieve reasonable recovery rates for anorectal anomalies to prevent FI in children. Research in Indonesia reported that the incidence of fecal incontinence caused by complications from Posterosagittal Anorectoplasty (PSARP) surgery in children with anorectal malformations is 5.8%. 10 After anoplasty, different supplementary therapies have been tried to enhance recovery rates. Still, conservative methods have not produced optimal results yet. 11–13 The secretome, composed of cytokines, proteins, chemokines, extracellular vesicles, and growth factors released by Mesenchymal Stem Cells (MSCs), has shown significant promise in tissue repair and regeneration. 14 Wound treatment with the secretome can significantly accelerate new tissue formation, collagen deposition, and re-epithelialization, which is mediated by growth factors such as vascular endothelial growth factor (VEGF). 15 VEGF expression is associated -Abstract Truncated-

Role of Hypoxic Secretome from Mesenchymal Stem Cells in Enhancing Tissue Repair: Regulatory Effects on HIF-1α, VEGF, and Fibroblast in a Sphincterotomy Rat Model